2019
DOI: 10.1111/jdi.12998
|View full text |Cite
|
Sign up to set email alerts
|

Key genes and co‐expression network analysis in the livers of type 2 diabetes patients

Abstract: Aims/Introduction The incidence of type 2 diabetes is increasing worldwide. Hepatic insulin resistance and liver lipid accumulation contributes to type 2 diabetes development. The aim of the present study was to investigate the key gene pathways and co‐expression networks in the livers of type 2 diabetes patients. Materials and Methods Dataset GSE 15653 containing nine healthy individuals and nine type 2 diabetes patients was downloaded from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 57 publications
0
16
0
Order By: Relevance
“…Although the rs2477088 variant has not been previously linked to any T2DM manifestations, PDE4DIP , also known as myomegalin or cardiomyopathy-associated protein 2, is a well-known contributor of the microtubule control process [ 36 ] and some previous evidence exist indicating on the potential role of the gene in macrovascular diseases and T2DM. The exome sequencing has revealed a rare variant of PDE4DIP , which significantly increases the risk of ischemic stroke [ 37 ], moreover, CpG island methylation in leukocytes annotated to PDE4DIP contributes to the epigenetic fingerprint of myocardial infarction [ 38 ], and finally, the gene is also significantly downregulated in liver of T2DM patients [ 39 ]. Another risk allele (rs4852954) identified in the analysis of macrovascular complications is located near the N-Acetyltransferase 8 coding gene ( NAT8 ) and has been previously associated with systolic blood pressure and renal function in the Estonian population [ 40 ] which is genetically close to the Latvian population [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although the rs2477088 variant has not been previously linked to any T2DM manifestations, PDE4DIP , also known as myomegalin or cardiomyopathy-associated protein 2, is a well-known contributor of the microtubule control process [ 36 ] and some previous evidence exist indicating on the potential role of the gene in macrovascular diseases and T2DM. The exome sequencing has revealed a rare variant of PDE4DIP , which significantly increases the risk of ischemic stroke [ 37 ], moreover, CpG island methylation in leukocytes annotated to PDE4DIP contributes to the epigenetic fingerprint of myocardial infarction [ 38 ], and finally, the gene is also significantly downregulated in liver of T2DM patients [ 39 ]. Another risk allele (rs4852954) identified in the analysis of macrovascular complications is located near the N-Acetyltransferase 8 coding gene ( NAT8 ) and has been previously associated with systolic blood pressure and renal function in the Estonian population [ 40 ] which is genetically close to the Latvian population [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…TRIM41 targets nucleoproteins for ubiquitination and protein degradation [ 90 ]. Little is known about the association between ANAPC13 and T2DM; however, it has been suggested to be one of the key differentially expressed genes in the livers of T2DM patients [ 91 ]. UBE2C overexpression is involved in the mis-segregation of chromosomes and alters the cell cycle process, facilitating cell proliferation.…”
Section: Discussionmentioning
confidence: 99%
“…The weighted correlations between ATAAD and all genes in GSE52093 or GSE98770 were analyzed by WGCNA package respectively as previously described ( Li et al, 2018 ). The soft threshold power was calculated automatically.…”
Section: Methodsmentioning
confidence: 99%